CTA
IMPV

Carillon Tower Advisers’s Imperva, Inc. IMPV Stock Holding History

Carillon Tower Advisers’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-787,515
Closed -$38M – 488
2018
Q2 		$38M Sell
787,515
-139,499
-15% -$6.67M 0.3% 121
2018
Q1 		$39.5M Hold
927,014
– – 0.31% 102
2017
Q4 		$36.8K Buy
+927,014
New +$38.6M 0.39% 92

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carillon Tower Advisers's IMPV Position: Q3 2018 in Review

Carillon Tower Advisers sold out of Imperva, Inc. (IMPV) in Q3 2018, closing a stake of 787,515 shares — an estimated $38M sold.

Carillon Tower Advisers first reported a position in IMPV in Q4 2017 and held it in 3 quarters. The position peaked at $39.5M in Q1 2018. 168 funds tracked by Wall St. Rank hold IMPV as of Q3 2018.

  • Carillon Tower Advisers reported no remaining Imperva, Inc. position as of Q3 2018 after selling out during the quarter.
  • Carillon Tower Advisers sold 787,515 Imperva, Inc. shares in Q3 2018, an estimated $38M.
  • Carillon Tower Advisers first reported a position in Imperva, Inc. in Q4 2017 and held it in 3 quarters.
  • Carillon Tower Advisers's Imperva, Inc. position peaked at $39.5M in Q1 2018.
  • 168 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2018.

Based on Carillon Tower Advisers's 13F filing for Q3 2018, filed 13 Nov 2018.